Nexalin Technology, Inc. (NXL)Healthcare | Medical Devices | Houston, United States | NasdaqCM
0.46 USD
0.00
(-0.258%) ⇩
(April 17, 2026, 4 p.m.
EDT)
After hours: 0.47 +0.01 (1.943%) ⇧ (April 17, 2026, 7:13 p.m. EDT) Short-term: ☆☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ★☆☆☆☆ |
Hot Take | April 19, 2026, 1:01 a.m. EDT
Despite a recent pop from$0.35 to$0.46 driven by news (AI clinic, earnings beat), the data confirms a deep value trap: negative earnings, negative cash flow, a massive price-to-sales ratio (31.6x), and a 45-day forecast model explicitly predicting a -23% decline, signaling a high-probability short-term downside. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.144002 |
| AutoTheta | 0.154378 |
| AutoETS | 0.319004 |
| MSTL | 0.344954 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 44% |
| H-stat | 9.67 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.729 |
| Excess Kurtosis | -0.10 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 0.018 |
| Market Cap | 9,535,476 |
| Forward P/E | -1.49 |
| Beta | 4.23 |
| Website | https://www.nexalin.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.7329873 |
| Address1 | 1,776 Yorktown |
| Address2 | Suite 550 |
| All Time High | 4.49 |
| All Time Low | 0.253 |
| Ask | 0.5889 |
| Ask Size | 2 |
| Average Analyst Rating | 2.0 - Buy |
| Average Daily Volume10 Day | 1,945,230 |
| Average Daily Volume3 Month | 596,403 |
| Average Volume | 596,403 |
| Average Volume10Days | 1,945,230 |
| Beta | 4.229 |
| Bid | 0.336 |
| Bid Size | 2 |
| Book Value | 0.195 |
| City | Houston |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.4633 |
| Current Ratio | 4.845 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 0.48 |
| Day Low | 0.448 |
| Display Name | Nexalin Technology |
| Ebitda | -8,369,344 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.694 |
| Enterprise To Revenue | 19.268 |
| Enterprise Value | 5,812,264 |
| Eps Current Year | -0.35 |
| Eps Forward | -0.31 |
| Eps Trailing Twelve Months | -0.5 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.43658 |
| Fifty Day Average Change | 0.026719987 |
| Fifty Day Average Change Percent | 0.06120296 |
| Fifty Two Week Change Percent | -73.29873 |
| Fifty Two Week High | 2.0 |
| Fifty Two Week High Change | -1.5367 |
| Fifty Two Week High Change Percent | -0.76835 |
| Fifty Two Week Low | 0.33 |
| Fifty Two Week Low Change | 0.13329998 |
| Fifty Two Week Low Change Percent | 0.4039393 |
| Fifty Two Week Range | 0.33 - 2.0 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,663,335,000,000 |
| Float Shares | 17,861,164 |
| Forward Eps | -0.31 |
| Forward P E | -1.4945161 |
| Free Cashflow | -1,950,561 |
| Full Exchange Name | NasdaqCM |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.79654 |
| Gross Profits | 240,274 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.11231 |
| Held Percent Institutions | 0.05994 |
| Implied Shares Outstanding | 20,581,646 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas. |
| Long Name | Nexalin Technology, Inc. |
| Market | us_market |
| Market Cap | 9,535,476 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_1763227626 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -8,222,181 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 9,535,476 |
| Number Of Analyst Opinions | 1 |
| Open | 0.457 |
| Operating Cashflow | -4,957,658 |
| Operating Margins | -14.0386095 |
| Payout Ratio | 0.0 |
| Phone | 832 260 0222 |
| Post Market Change | 0.009000003 |
| Post Market Change Percent | 1.9425865 |
| Post Market Price | 0.4723 |
| Post Market Time | 1,776,467,626 |
| Previous Close | 0.4645 |
| Price Eps Current Year | -1.3237143 |
| Price Hint | 4 |
| Price To Book | 2.3758974 |
| Price To Sales Trailing12 Months | 31.611374 |
| Profit Margins | 0.0 |
| Quick Ratio | 4.288 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 2.0 |
| Region | US |
| Regular Market Change | -0.00120002 |
| Regular Market Change Percent | -0.258347 |
| Regular Market Day High | 0.48 |
| Regular Market Day Low | 0.448 |
| Regular Market Day Range | 0.448 - 0.48 |
| Regular Market Open | 0.457 |
| Regular Market Previous Close | 0.4645 |
| Regular Market Price | 0.4633 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 106,371 |
| Return On Assets | -1.18408 |
| Return On Equity | -2.21502 |
| Revenue Growth | 5.325 |
| Revenue Per Share | 0.018 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 20,581,646 |
| Shares Percent Shares Out | 0.0234 |
| Shares Short | 481,971 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 598,666 |
| Short Name | Nexalin Technology, Inc. |
| Short Percent Of Float | 0.0247 |
| Short Ratio | 4.03 |
| Source Interval | 15 |
| State | TX |
| Symbol | NXL |
| Target High Price | 2.0 |
| Target Low Price | 2.0 |
| Target Mean Price | 2.0 |
| Target Median Price | 2.0 |
| Total Cash | 3,723,212 |
| Total Cash Per Share | 0.181 |
| Total Debt | 0 |
| Total Revenue | 301,647 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.5 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 0.839935 |
| Two Hundred Day Average Change | -0.37663502 |
| Two Hundred Day Average Change Percent | -0.4484097 |
| Type Disp | Equity |
| Volume | 106,371 |
| Website | https://www.nexalin.com |
| Zip | 77,056 |